A Lifelong Solution for a Chronic Condition
Paragate is developing an implantable device for the treatment of fluid overload in patients suffering from chronic heart or kidney failure.
We at Paragate are committed to shifting the weight of care from frequent, repeated hospital admissions to active, continuous home-based care.
Paragate’s IPUD (Implantable Peritoneal Ultrafiltration Device) is a minimally invasive and fully implantable device, serving as a mechanical bypass to the kidneys, to actively, continuously and non-aggressively remove excess fluid from the body, to keep patients balanced at home.
IPUD works 24/7/365 to actively treat patients and maintain fluid balance. The system also streams the collected sensed data to the management platform, the physician can remotely monitor patient and the IPUD performance, allowing a patient tailored therapy.
Supported by
